Global Spasticity Treatment Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Spasticity Treatment Market was valued at $4.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.8% CAGR, to an estimated market size of $6.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global spasticity treatment market encompasses a comprehensive range of therapeutic interventions, including pharmacological agents (oral muscle relaxants, botulinum toxins, and cannabinoids), physical and occupational therapies, surgical procedures (such as selective dorsal rhizotomy), and neurostimulation devices designed to manage muscle hypertonicity and involuntary spasms resulting from upper motor neuron damage in conditions like cerebral palsy, multiple sclerosis, and stroke.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Spasticity Treatment Market in the period 2025-30:
- Integration of robotic-assisted therapy and virtual reality is transforming traditional rehabilitation by enhancing motor function outcomes and patient engagement.
- The development of long-acting botulinum toxin formulations is reducing injection frequency and improving long-term symptom management for focal spasticity.
- A significant shift toward personalized medicine is driving the use of pharmacogenomics to tailor drug selection and dosing regimens to individual patient profiles.
- Rising global prevalence of neurological disorders, particularly stroke and multiple sclerosis in aging populations, is creating a sustained demand for chronic spasticity management.
- Adoption of digital health tools and telemedicine is facilitating remote patient monitoring and improving adherence to home-based physical therapy protocols.
- Advancements in intrathecal drug delivery systems and minimally invasive neuromodulation are providing new options for patients refractory to oral medications.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Drug Therapy
- Physical & Occupational Therapy
- Surgical & Neurostimulation Devices